Published in Pol Tyg Lek on May 16, 1973
EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 2.75
Microheterogeneity forms of alpha 1-acid glycoprotein as indicators of rheumatoid arthritis activity. Clin Chim Acta (1987) 0.98
Microheterogeneity of alpha 1-acid glycoprotein in the detection of intercurrent infection in systemic lupus erythematosus. Arthritis Rheum (1987) 0.98
Determination of lectin-sugar dissociation constants by agarose affinity electrophoresis. Anal Biochem (1986) 0.96
[Serotonin concentration in serum of patients with generalized tendomyopathy (fibromyalgia) and chronic polyarthritis]. Med Klin (Munich) (1993) 0.88
[Splenic rupture in the course of systemic lupus erythematosis]. Pol Tyg Lek (1971) 0.88
Problems of diagnostic failure in gouty arthritis. Ann Clin Res (1972) 0.86
TNF-alpha gene polymorphism does not affect the clinical and radiological outcome of rheumatoid arthritis. Rheumatol Int (2000) 0.86
Still's disease in children and adults: a distinct pattern of acute-phase proteins. Clin Rheumatol (1998) 0.86
Comparison of three immunoassays for C-reactive protein determination. Arch Immunol Ther Exp (Warsz) (1985) 0.84
Intra-articular treatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist tropisetron. A double-blind study compared with methylprednisolone. Scand J Rheumatol Suppl (2004) 0.83
Glycosylation of alpha 1-acid glycoprotein in systemic onset juvenile rheumatoid arthritis and acute bacterial infection: value in differential diagnosis. J Rheumatol (1993) 0.82
Cytochemical studies of peripheral blood granulocytes and lymphocytes in patients with systemic lupus erythematosus. Pol Med Sci Hist Bull (1976) 0.80
The differences in the expression of CD45 isoforms on peripheral blood lymphocytes derived from patients with seasonal or perennial atopic allergy. Tohoku J Exp Med (1997) 0.80
Microheterogeneity of alpha 1-acid glycoprotein in early and established rheumatoid arthritis. J Rheumatol (1993) 0.79
[LE phenomenon in pleural effusion]. Pol Arch Med Wewn (1981) 0.78
[The heteroglycan profile of acute phase proteins in the differentiation of inflammatory processes]. Z Rheumatol (1990) 0.78
[An unusual case of Kartagener's syndrome associated with rheumatoid arthritis]. Pol Arch Med Wewn (1996) 0.78
Effect of thyroid hormone on the myosin heavy chain isoforms in slow and fast muscles of the rat. Acta Biochim Pol (1999) 0.78
Do changes in clinical improvement in rheumatoid arthritis patients treated with immunosuppressive drugs reflect the changes in acute phase proteins? Ups J Med Sci (1995) 0.77
Effects of mibefradil, a blocker of T-type Ca2+ channels, in single myocytes and intact muscle of guinea-pig heart. J Physiol Pharmacol (1998) 0.77
Microheterogeneity of alpha 1 acid glycoprotein in rheumatoid arthritis: dependent on disease duration? Ann Rheum Dis (1993) 0.77
Circulating interleukin 10 and interleukin-6 serum levels in rheumatoid arthritis patients treated with methotrexate or gold salts: preliminary report. Inflamm Res (1995) 0.77
Comparative evaluation of various methods of detecting antibodies against soluble nuclear antigens. Arch Immunol Ther Exp (Warsz) (1982) 0.77
Studies on microheterogeneity of acute-phase proteins in rheumatoid arthritis by using crossed affinoimmuno-electrophoresis with free concanavalin A. Behring Inst Mitt (1986) 0.77
Changes in agalactosyl IgG levels correlate with radiological progression in early rheumatoid arthritis. Ann Med (1996) 0.76
Cytochemical studies of rosette-forming cells. Z Immunitatsforsch Exp Klin Immunol (1975) 0.76
[LE phenomenon in the synovial fluid in rheumatoid arthritis]. Reumatologia (1981) 0.76
The effect of methotrexate and azathioprine on the serum levels of IgA-alpha 1-antitrypsin complex in juvenile chronic arthritis. Braz J Med Biol Res (1997) 0.75
Immunological studies in patients with rheumatoid arthritis treated with methotrexate or cyclophosphamide. Z Rheumatol (1994) 0.75
Does IgA-alpha1 antitrypsin complex correlate with IgM, IgG and IgA rheumatoid factor in early rheumatoid arthritis? Mater Med Pol (1995) 0.75
[Immunological mechanism in the pathogenesis of heart diseases]. Kardiol Pol (1977) 0.75
[Effects of chloroform, trichorethylene and fluotane anesthesias on the liver activity in rabbits]. Acta Pol Pharm (1966) 0.75
[Cytochemical studies of peripheral granulocytes and lymphocytes in patients wirh systemic lupus erythematous]. Pol Arch Med Wewn (1975) 0.75
C-reactive protein in management of children's burns. Ann Clin Res (1987) 0.75
[Morphological differentiation of peripheral blood lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus]. Pol Tyg Lek (1975) 0.75
[Mechanisms of autoimmunization]. Pol Arch Med Wewn (1985) 0.75
[Echocardiographic heart assessment in systemic lupus erythematosus]. Pol Merkur Lekarski (1997) 0.75
[Wolff-Parkinson-White syndrome developing into atrioventricular block]. Kardiol Pol (1968) 0.75
Subpopulations of blood lymphocytes in patients with rheumatoid arthritis. Z Immunitatsforsch Immunobiol (1976) 0.75
[IgM level and the presence of Australia antigen in serum of patients with viral hepatitis]. Pol Tyg Lek (1974) 0.75
[Immunologic mechanism of immediate hypersensitivity of the anaphylaxis type]. Postepy Hig Med Dosw (1973) 0.75
[Bone tissue metabolism in systematic lupus erythematosus patients treated with glucocorticosteroids]. Pol Arch Med Wewn (2001) 0.75
Activity of lysosomal enzymes and glycogen content of phytohemagglutinin-stimulated lymphocytes in patients with rheumatoid arthritis. Pol Med Sci Hist Bull (1976) 0.75
[Detection of rheumatoid factor by the rheumatoid rosette method]. Pol Arch Med Wewn (1976) 0.75
[Clinical immunology--a new branch of medicine]. Pol Tyg Lek (1975) 0.75
Reliability of seromucoid as an indicator of rheumatoid arthritis activity. Scand J Rheumatol (1972) 0.75
Acute phase response in rheumatoid arthritis patients treated with immunosuppressive drugs. Mater Med Pol (1996) 0.75
Nabumetone induces less gastrointestinal mucosal changes than diclofenac retard. Clin Rheumatol (1999) 0.75
Effect of cyclophosphamide on the thymus in mice. Arch Immunol Ther Exp (Warsz) (1981) 0.75
[Indices of acute phase in myocardial infarct]. Pol Arch Med Wewn (1971) 0.75
[Immunochemical studies of protein antigens in human erythrocytes]. Acta Physiol Pol (1972) 0.75
[Prognostic value of immunoglobulin determination in protracted forms of viral hepatitis]. Pol Tyg Lek (1973) 0.75
Occurrence of HLA antigens in patients with ankylosing spondylitis and in their families. Arch Immunol Ther Exp (Warsz) (1983) 0.75
Antiphospholipid antibodies and disturbances of phospholipid dependent coagulation tests in patients with systemic sclerosis and severe peripheral ischaemia. Thromb Res (1996) 0.75
[Immunologic mechanism of anaphylactic type reactions of immediate hypersensitivity]. Postepy Hig Med Dosw (1973) 0.75
On the source of Ca(2+) activating the tonic component of contraction of myocytes of guinea pig heart. Cardiovasc Res (2001) 0.75
[Subclavian steal syndrome of arteriosclerotic origin]. Pol Tyg Lek (1969) 0.75
Properties of ventricular myocytes isolated from the hypertrophied and failing hearts of spontaneously hypertensive rats. J Physiol Pharmacol (1999) 0.75
[Report of the Committee on Establishing Criteria of Systemic Lupus Erythematosus]. Reumatologia (1975) 0.75
[Case of gout with unusual tumors within joints]. Reumatologia (1971) 0.75
The influence of cyclophosphamide on lymph node and peripheral blood lymphocytes in mice. Arch Immunol Ther Exp (Warsz) (1978) 0.75
Effect of cyclophosphamide on the immune response to sheep erythrocytes in the mouse. II. A study of enzyme activities in the draining lymph node. Z Immunitatsforsch Exp Klin Immunol (1976) 0.75
[The effect of cyclophosphamide on the immunologic phenomena in experimental animals]. Med Dosw (1966) 0.75
[Nail-fold capillaroscopy in connective tissue diseases. Methods of studying the physiomorphology of capillaries]. Pol Tyg Lek (1973) 0.75
[Activity of lysosomal enzymes and glycogen content in PHA-activated lymphocytes in patients with rheumatoid arthritis]. Pol Arch Med Wewn (1975) 0.75
[Proliferative response of the lymphocytes in atopic allergy]. Pol Tyg Lek (1986) 0.75
The coexistence of mutilating rheumatoid arthritis, progressive systemic sclerosis and polycythemia vera--a case report. Z Rheumatol (1993) 0.75
Effect of cyclophosphamide on the immune response to sheep erythrocytes in the mouse. I. A study of cytological events in the draining lymph node. Z Immunitatsforsch Exp Klin Immunol (1974) 0.75
[Effect of articular fluid on leukocyte migration inhibition in patients with rheumatoid arthritis]. Reumatologia (1975) 0.75
[Changes in the osteoarticular system preceding the appearance of myeloblastic leukemia]. Reumatologia (1972) 0.75
[Peripheral blood lymphocyte populations in viral hepatitis]. Pol Arch Med Wewn (1976) 0.75
[Fetal hemoglobin in congenital heart disease]. Pol Arch Med Wewn (1967) 0.75
Lectin inhibition system for determination of concanavalin A glycoprotein complexes dissociation constants in agarose affinity electrophoresis. Arch Immunol Ther Exp (Warsz) (1985) 0.75
[Evaluation of peripheral leukocyte migration inhibition test with aggregated human gamma globulin in patients with rheumatoid arthritis]. Pol Tyg Lek (1975) 0.75
Studies of acute phase reactants in myocardial infarction. Pol Med J (1972) 0.75
[Diagnostic difficultues in differentiation of dermatomyositis in the light of an observed case]. Pol Tyg Lek (1968) 0.75
Effect of aggregated human gamma-globin on leukocyte migration-inhibitory test in patients with rheumatoid arthritis. Pol Med Sci Hist Bull (1977) 0.75
[Biological and physico-chemical properties of reagins]. Postepy Hig Med Dosw (1972) 0.75
[Pharmacological control of immune phenomena]. Reumatologia (1966) 0.75
[Clinical evaluation of methindol]. Reumatologia (1971) 0.75
[Pentaxins: their structure and function]. Postepy Hig Med Dosw (1988) 0.75
The effect of C-reactive protein on the PHA-induced proliferation of human peripheral blood lymphocytes. Arch Immunol Ther Exp (Warsz) (1985) 0.75
[Immunologic aspects of the effect of corticosteroids]. Pneumonol Pol (1976) 0.75
[Effect of ultrasounds on serum gamma globulin in man]. Pol Tyg Lek (1970) 0.75
The presence of HLA-DR B1 shared motif does not influence cyclophosphamide and methotrexate cytotoxicity in rheumatoid arthritis patients. J Investig Allergol Clin Immunol (2001) 0.75
[Effect of cyclophosphamide on serum proteins in the rat]. Acta Pol Pharm (1967) 0.75
[Pseudo-lupus erythematosus in 6 siblings]. Pol Arch Med Wewn (1973) 0.75
[Disturbances of immune reactions in the families of patients with systemic lupus erythematosus]. Pol Tyg Lek (1970) 0.75
[Azathioprine and cyclophosphamide in the treatment of rheumatoid arthritis]. Pol Arch Med Wewn (1975) 0.75
Effect of cyclophosphamide-induced elimination of lymphocytes from the spleen and lymph node on immune response in mice. Arch Immunol Ther Exp (Warsz) (1981) 0.75
[Use of indirect immunofluorescence in the determination of antiglobulin factors]. Pol Arch Med Wewn (1976) 0.75
[Role of cycl AMP in anaphylactic reaction]. Postepy Hig Med Dosw (1976) 0.75
HLA antigens and rheumatoid arthritis. Arch Immunol Ther Exp (Warsz) (1977) 0.75
Effect of cyclophosphamide on spleen lymphocytes in mice. Arch Immunol Ther Exp (Warsz) (1981) 0.75